Research Article

The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant

Table 2

The clinical manifestations and virological features of C/D recombinant.

Items Statistical description percentage (amount)/median (interquartile range)Statistical value value
C/D recombinant infected patients ()All patients ()

EthnicityTibetan 66.67% ()
Han 33.33 ()
Tibetan 5.14% ()
Han 94.86% ()
Fisher<0.001
GenderMale 77.78% ()
Female 22.22% ()
Male 81.87% ()
Female 18.13% ()
= 0.0001
Age40 (22.5)33.50 (15)0.388
AlcoholAlcohol-abuse 44.44% ()
Alcohol-free 55.56% ()
Alcohol-abuse 82.48% ()
Alcohol-free 17.52% ()
= 6.06510.01379
Family historyPositive 77.78% ()
Negative 22.22% ()
Positive 39.58% ()
Negative 60.42% ()
= 3.83640.05015
ALT (IU/L)38 (32)40 (42)0.328
TB (umol/L)11.50 (7.41)12.40 (9.44)0.542
ALB (g/L)47.50 (9.10)50.80 (22.40)0.278
ALP (IU/L)79 (33.25)91 (42.25)0.228
GGT (IU/L)45.50 (34.50)46 (54)0.962
AFP (ng/mL)3.55 (6.27)3.42 (3.54)0.944
HBeAgPositive 77.78% ()
Negative 22.22% ()
Positive 68.28% ()
Negative 31.72% ()
= 0.0584560.809
log10 HBVDNA (IU/mL)6.69 (1.62)7.27 (3.04)0.26
BCP mutationA1762T/G1764A 44.44% ()
G1896A 11.11% ()
A1762T/G1764A/G1896A 11.11% ()
Not detected 33.33% ()
A1762T/G1764A 16.01% ()
G1896A 18.13% ()
A1762T/G1764A/G1896A 3.02% ()
Others 3.02% ()
Not detected 59.82% ()
Fisher0.03049
Fibroscan (Kpa)11.5 (8.55)7.95 (6.42)0.921